"Cefotaxime" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Semisynthetic broad-spectrum cephalosporin.
| Descriptor ID |
D002439
|
| MeSH Number(s) |
D02.065.589.099.249.190.190 D02.886.665.074.190.190 D03.633.100.300.249.190.190
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cefotaxime".
Below are MeSH descriptors whose meaning is more specific than "Cefotaxime".
This graph shows the total number of publications written about "Cefotaxime" by people in this website by year, and whether "Cefotaxime" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cefotaxime" by people in Profiles.
-
Hackel MA, Iaconis JP, Karlowsky JA, Sahm DF. Analysis of Potential ?-Lactam Surrogates To Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae. J Clin Microbiol. 2018 04; 56(4).
-
Karlowsky JA, Jones ME, Draghi DC, Sahm DF. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime. Antimicrob Agents Chemother. 2003 Oct; 47(10):3155-60.
-
Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations. J Clin Microbiol. 2002 Feb; 40(2):669-74.
-
Lehman SS. An uncommon cause of ophthalmia neonatorum: Neisseria meningitidis. J AAPOS. 1999 Oct; 3(5):316.
-
Gaughan WJ, Hassan MH, McCue PA, Burke JF, Sharma K. Association of IgA nephropathy with Clostridium difficile colitis. Am J Kidney Dis. 1999 Oct; 34(4):e16.
-
Bradford PA, Yang Y, Sahm D, Grope I, Gardovska D, Storch G. CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob Agents Chemother. 1998 Aug; 42(8):1980-4.
-
Salen PN, Eppes S. Morganella morganii: a newly reported, rare cause of neonatal sepsis. Acad Emerg Med. 1997 Jul; 4(7):711-4.
-
Anania WC, Chinkes SL, Rosen RC, Turner PR, Helfand AE. A selective clinical trial of ceftizoxime. J Am Podiatr Med Assoc. 1987 Dec; 77(12):648-52.
-
Parish LC, Asper R. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime. Am J Med. 1987 Apr 27; 82(4A):227-9.
-
Parish LC, Parks DB, Layne PP, Uri JV. Ceftizoxime treatment of cutaneous and subcutaneous tissue infections. Clin Ther. 1984; 6(5):613-9.